QuantHealth Taps OMNY Health to Improve Dataset Structures for its AI Platform
July 02 2024 - 9:00AM
Business Wire
Data Collaboration Advances QuantHealth’s Trial
Simulation Capabilities
QuantHealth, the leading AI-driven clinical trial design
company, today announced a partnership with OMNY Health, the
premier healthcare ecosystem for facilitating compliant
cross-industry health data sharing. This collaboration aims to
unlock novel insights from OMNY Health's vast network of
de-identified data, fostering new opportunities for clinical
trials, evidence-based practice, and medical research for
QuantHealth’s customers, which include four out of the five largest
pharmaceutical companies globally.
By integrating diverse EHRs into organized, de-identified
research data products, OMNY equips researchers and providers with
comprehensive information to address disparities in clinical trials
and close significant demographic information gaps in drug
discovery and development. OMNY's extensive data portfolio supports
downstream analytic needs for life sciences innovation. The
partnership with QuantHealth will unlock insights to accelerate
life-changing innovation, further underscoring data as the power
source for AI companies.
QuantHealth’s AI technology, trained on a dataset of 350 million
patients, enhances clinical trial timelines, mitigates trial risks,
and identifies sub-populations likely to respond to treatments.
This collaboration will help QuantHealth's pharmaceutical partners
expedite drug development through simulated clinical trials
informed by real-world evidence and predicted clinical trial
outcomes, drug efficacy, and patient responses.
“Biotech is entering a vibrant part of life sciences history,”
said Omri Matalon, VP Clinical Data Science and Head of R&D
Operations. "This partnership with OMNY Health furthers
QuantHealth’s commitment to quality data and access for our
partners. "This diverse and highly organized, de-identified
research and data will optimize our simulated clinical trials,
enabling us to provide the highest quality insights to our life
sciences partners and continue to revolutionize the research and
development arena."
This partnership represents OMNY Health's focus on life sciences
data and accelerating diverse participation in clinical trials,
significantly enhancing its real-world data ecosystem, which
supports compliant research AI company partnerships at scale. By
facilitating secure and mutually beneficial data sharing, OMNY
helps companies like QuantHealth simulate trials at scale and
expedite, de-risk, and optimize drug development, to provide the
world with effective medication expeditiously.
"Life sciences organizations and healthcare providers often face
time and budget constraints that limit their ability to utilize
their data effectively. By partnering with QuantHealth, we can
break down these barriers and provide organized, on-demand, and
data-driven answers to pressing clinical questions. This
collaboration will accelerate drug development and optimize
clinical trials, leading to improved therapeutic outcomes and
enhanced patient care," said Mitesh Rao, CEO, of OMNY Health. "Our
mission is to free data from silos, enabling it to be shared,
analyzed, and transformed into life-saving treatments and improved
patient care."
This collaboration follows QuantHealth's recent strategic
investment from Accenture Ventures and a leading CRO firm, bringing
its Series A funding total to $17M. Founded in 2020, QuantHealth
aims to help pharmaceutical companies advance and de-risk their
programs by using AI to simulate clinical trials. The company’s
technology predicts clinical trial outcomes, drug efficacy, and
patient responses, delivering real-world evidence and enhancing
clinical trial success.
About OMNY Health
OMNY Health™ is a national data ecosystem connecting the world
of healthcare to fuel partnerships that improve clinical outcomes
and drive patient care. OMNY’s dynamic partnerships with specialty
health networks, healthcare systems, academic medical centers, and
integrated delivery networks span all fifty states and cover over
75 million patient lives. The company’s comprehensive data layer
powers health tech companies to drive the next generation of
innovation. The platform serves as a centralized resource for life
sciences and healthcare provider groups to facilitate
mutually-beneficial data sharing and research collaboration at
scale, fueling innovation where patients need it the most. OMNY
Health’s data ecosystem now reflects more than seven years of
historical data encompassing more than 2 billion clinical notes
from 300,000+ providers across 200+ specialties - and is growing.
For more information, visit www.omnyhealth.com.
About QuantHealth
90% of drugs fail the clinical stage, representing a direct $45B
annual waste to pharma companies. To address this challenge at its
core, QuantHealth's Clinical-Simulator predicts how each patient in
a clinical trial will respond to treatment, allowing trial design
teams to predict how an entire clinical trial will play out and
adapt accordingly. Based on its novel AI engine and a vast dataset
of 350m patients and over 700K therapeutics, QuantHealth's
simulator can predict clinical trial results with high accuracy,
allowing users to answer mission-critical questions such as trial
go/no-go, cohort optimization, drug repurposing, and more.
QuantHealth was founded by healthcare experts who led commercial,
product, and data science at various leading companies in the US
and Israel. QuantHealth is backed by expert Life-Science investors
in the US, Europe, and Israel and is supported by an advisory board
of physicians and scientists from leading academic institutions. To
learn more, visit https://quanthealth.ai/.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240702857396/en/
Chloe Fredericksdorf omnyhealth@solcomms.co